Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4

被引:44
|
作者
Byon, Chang Hyun [2 ]
Hardy, Robert W. [1 ]
Ren, Changchun [1 ]
Ponnazhagan, Selvarangan [1 ]
Welch, Danny R. [1 ,2 ]
McDonald, Jay M. [1 ,3 ]
Chen, Yabing [1 ]
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA
[3] Vet Adm Med Ctr, Birmingham, AL USA
关键词
free fatty acids; breast cancer cell; migration; PAI-1; SMAD4; IN-VITRO; LINOLEIC-ACID; GROWTH; GENE; OBESITY; EXPRESSION; INVASION; IDENTIFICATION; METASTASIS; OVERWEIGHT;
D O I
10.1038/labinvest.2009.97
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Obesity is a risk factor for breast cancer and is associated with increased plasma concentrations of free fatty acids (FFAs). We and others have demonstrated that FFA induces plasminogen activator inhibitor-1 (PAI-1) expression in a variety of cells. Emerging evidence supports elevation of PAI-1 as a prognostic marker for breast cancer. Therefore, we hypothesized that FFAs might increase expression of PAI-1 in breast cancer cells and facilitate breast cancer progression. Secreted PAI-1 was higher in invasive and metastatic MDA-MB-231 cells compared with less invasive and non-metastatic Hs578T cells. Utilizing FFAs with different saturation and chain lengths, we demonstrated that linoleic acid induced expression of PAI-1 in MDA-MB-231 cells. Linoleic acid also induced in vitro migration of MDA-MB-231. By contrast, other FFAs tested had little or no effect on PAI-1 expression or migration. Linoleic acid-induced breast cancer cell migration was completely inhibited by virally expressed antisense PAI-1 RNA. Furthermore, increased expression of PAI-1 by FFAs was not detected in the SMAD4-deficient MDA-MB-468 breast carcinoma cells. Electrophoretic mobility-shift assay confirmed that linoleic acid-induced expression of PAI-1 was mediated, at least in part, by SMAD4 in MDA-MB-231 cells. That linoleic acid induces PAI-1 expression in breast cancer cells through SMAD4 provides a novel insight into understanding the relationships between two migration-associated molecules, FFAs, and PAI-1. Laboratory Investigation (2009) 89, 1221-1228; doi: 10.1038/labinvest.2009.97; published online 14 September 2009
引用
收藏
页码:1221 / 1228
页数:8
相关论文
共 50 条
  • [31] Smad4 mediates malignant behaviors of human ovarian carcinoma cell through the effect on expressions of E-cadherin, plasminogen activator inhibitor-1 and VEGF (vol 43, pg 554, 2010)
    Chen, Chen
    Sun, Ming-Zhong
    Liu, Shuqing
    Yeh, Dongmei
    Yu, Lijun
    Song, Yang
    Gong, Linlin
    Hao, Lihong
    Shao, Shujuan
    BMB REPORTS, 2020, 53 (04) : 240 - 240
  • [32] Protumorigenic Activity of Plasminogen Activator Inhibitor-1 Through an Antiapoptotic Function
    Fang, Hua
    Placencio, Veronica R.
    DeClerck, Yves A.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (19): : 1470 - 1484
  • [33] The role of plasminogen activator inhibitor-1 as inhibitor of platelet and megakaryoblastic cell adhesion
    Wohn, KD
    Schmidt, T
    Kanse, SM
    Yutzy, B
    Germer, M
    Morgenstern, E
    Preissner, KT
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (04) : 901 - 908
  • [34] Tanshinones Increase Fibrinolysis through Inhibition of Plasminogen Activator Inhibitor-1
    Xiao, Ying-Hong
    Yang, Long-Fei
    Feng, Xue-Chao
    Yang, Hong
    Ma, Tong-Hui
    CNS NEUROSCIENCE & THERAPEUTICS, 2012, 18 (05) : 436 - 438
  • [35] The prognostic influence of Plasminogen Activator Inhibitor-1 in early breast cancer is not related to estimates of angiogenesis
    Offersen, B.
    Riisbro, R.
    Knoop, A.
    Brunner, N.
    Overcaard, J.
    EJC SUPPLEMENTS, 2005, 3 (02): : 82 - 82
  • [36] Assessment of Plasminogen Activator Inhibitor-1(PAI-1) Biomarker in Women with Breast Cancer Disease
    AL-Nafakh, Zahraa Mohammed
    AL-Dujaili, Arshad Noori G.
    Rudha, Ammar Rasoul Mohammed
    8TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2020), 2020, 2290
  • [37] Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice
    Almholt, K
    Nielsen, BS
    Frandsen, TL
    Brünner, N
    Dano, K
    Johnsen, M
    ONCOGENE, 2003, 22 (28) : 4389 - 4397
  • [38] Metastasis of transgenic breast cancer in plasminogen activator inhibitor-1 gene-deficient mice
    Kasper Almholt
    Boye S Nielsen
    Thomas L Frandsen
    Nils Brünner
    Keld Danø
    Morten Johnsen
    Oncogene, 2003, 22 : 4389 - 4397
  • [39] Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer
    J-Y Pierga
    C Lainé-Bidron
    P Beuzeboc
    P De Crémoux
    P Pouillart
    H Magdelénat
    British Journal of Cancer, 1997, 76 : 537 - 540
  • [40] Plasminogen activator inhibitor-1 (PAI-1) is not related to response to neoadjuvant chemotherapy in breast cancer
    Pierga, JY
    LaineBidron, C
    Beuzeboc, P
    DeCremoux, P
    Pouillart, P
    Magdelenat, H
    BRITISH JOURNAL OF CANCER, 1997, 76 (04) : 537 - 540